Your Messages Inbox
Your Article Summary
See Latest ArticlesCovidien Receives FDA Clearance for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter with OxiMax SPD(TM) Alert
Covidien, 03/24/09
Covidien, a leading global provider of healthcare products, today announced that the United States Food and Drug Administration (FDA) has issued a 510(k)marketing clearance for the Nellcor OxiMax N-600x pulse oximeter with OxiMax SPD™ alert for adults. The OxiMax SPD feature enables the pulse oximeter to detect and alert clinicians of worrisome oxygen desaturation patterns, allowing them to make timely and more informed decisions about patient care.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor